This document is an excerpt from the EUR-Lex website
Document 02005D0873-20061209
Commission Decision of 30 November 2005 approving programmes for the eradication and monitoring of animal diseases, of certain TSEs, and for the prevention of zoonoses presented by the Member States for the year 2006 (notified under document number C(2005) 4621) (Text with EEA relevance) (2005/873/EC)
Consolidated text: Commission Decision of 30 November 2005 approving programmes for the eradication and monitoring of animal diseases, of certain TSEs, and for the prevention of zoonoses presented by the Member States for the year 2006 (notified under document number C(2005) 4621) (Text with EEA relevance) (2005/873/EC)
Commission Decision of 30 November 2005 approving programmes for the eradication and monitoring of animal diseases, of certain TSEs, and for the prevention of zoonoses presented by the Member States for the year 2006 (notified under document number C(2005) 4621) (Text with EEA relevance) (2005/873/EC)
02005D0873 — EN — 09.12.2006 — 002.001
This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document
COMMISSION DECISION of 30 November 2005 approving programmes for the eradication and monitoring of animal diseases, of certain TSEs, and for the prevention of zoonoses presented by the Member States for the year 2006 (notified under document number C(2005) 4621) (Text with EEA relevance) (OJ L 322 9.12.2005, p. 21) |
Amended by:
|
|
Official Journal |
||
No |
page |
date |
||
L 263 |
14 |
23.9.2006 |
||
L 346 |
59 |
9.12.2006 |
COMMISSION DECISION
of 30 November 2005
approving programmes for the eradication and monitoring of animal diseases, of certain TSEs, and for the prevention of zoonoses presented by the Member States for the year 2006
(notified under document number C(2005) 4621)
(Text with EEA relevance)
(2005/873/EC)
CHAPTER I
RABIES
Article 1
The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the purchase and distribution of vaccine plus baits for the programmes and shall not exceed:
EUR 390 000 for the Czech Republic;
EUR 750 000 for Germany;
EUR 990 000 for Estonia;
►M2 EUR 0 ◄ for France;
EUR 650 000 for Latvia;
►M2 EUR 0 ◄ for Lithuania;
EUR 180 000 for Austria;
EUR 3 750 000 for Poland;
EUR 300 000 for Slovenia;
EUR 400 000 for Slovakia;
EUR 100 000 for Finland.
The maximum amounts of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed:
for the purchase of one vaccine dose EUR 0,5 per dose for the programmes referred to in paragraph 2(c) and (d); and
for the purchase of one vaccine dose EUR 0,3 per dose for the other programmes referred to in paragraph 2.
CHAPTER II
BOVINE BRUCELLOSIS
Article 2
The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of laboratory tests, the compensation to owners for their losses due to the slaughter of animals subject to those programmes and the purchase of vaccine doses and shall not exceed:
EUR 300 000 for Greece;
EUR 6 000 000 for Spain;
EUR 1 750 000 for Ireland;
EUR 2 600 000 for Italy;
EUR 300 000 for Cyprus;
EUR 260 000 for Poland;
EUR 1 800 000 for Portugal;
EUR 1 900 000 for the United Kingdom.
The maximum amounts of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed:
for a rose bengal test |
EUR 0,2 per test; |
for a complement fixation test |
EUR 0,4 per test; |
for an ELISA test |
EUR 1 per test; |
for the purchase of one vaccine dose |
EUR 0,5 per dose. |
CHAPTER III
BOVINE TUBERCULOSIS
Article 3
The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the costs of tuberculin testing, the cost of laboratory tests and the compensation to owners for their losses due to the slaughter of animals subject to those programmes and shall not exceed:
►M2 EUR 135 000 ◄ for Estonia;
►M2 EUR 7 000 000 ◄ for Spain;
EUR 1 800 000 for Italy;
EUR 800 000 for Poland;
►M2 EUR 370 000 ◄ for Portugal.
The maximum amounts of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed:
for a tuberculin test |
EUR 0,8 per test; |
for a gamma-interferon test |
EUR 5 per test. |
CHAPTER IV
ENZOOTIC BOVINE LEUCOSIS
Article 4
The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of laboratory tests and compensation to owners for their losses due to the slaughter of animals subject to those programmes and shall not exceed:
EUR 5 000 for Estonia;
EUR 200 000 for Italy;
►M2 EUR 90 000 ◄ for Latvia;
EUR 10 000 0 for Lithuania;
►M2 EUR 400 000 ◄ for Portugal.
The maximum amounts of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed:
for an ELISA test |
EUR 0,5 per test; |
for an agar gel immune diffusion test |
EUR 0,5 per test. |
CHAPTER V
OVINE AND CAPRINE BRUCELLOSIS
Article 5
The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the purchase of vaccines, the cost of laboratory tests, the compensation to owners for their losses due to the slaughter of animals subject to those programmes and as regards the programme presented by Greece also the salaries of contractual veterinarians specially recruited for that programme and shall not exceed:
EUR 600 000 for Greece;
EUR 6 500 000 for Spain;
EUR 150 000 for France;
EUR 3 200 000 for Italy;
EUR 310 000 for Cyprus;
►M2 EUR 1 130 000 ◄ for Portugal.
The maximum amounts of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed:
for a rose bengal test |
EUR 0,2 per test; |
for a complement fixation test |
EUR 0,4 per test; |
for the purchase of one vaccine dose |
EUR 0,1 per dose. |
CHAPTER VI
BLUETONGUE
Article 6
The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of the laboratory tests for virological, serological and entomological surveillance, the purchase of traps and vaccines and shall not exceed:
►M2 EUR 4 200 000 ◄ for Spain;
EUR 150 000 for France;
EUR 1 000 000 for Italy;
EUR 1 250 000 for Portugal.
The maximum amounts of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed:
for an ELISA test |
EUR 2,5 per test; |
for the purchase of one vaccine dose |
EUR 0,5 per dose. |
CHAPTER VII
CERTAIN ZOONOTIC SALMONELLA IN BREEDING POULTRY
Article 7
The programmes for the control of salmonella in breeding poultry presented by Belgium, Denmark, Germany, France, Ireland, Italy, Cyprus, Latvia, the Netherlands, Austria, Portugal and Slovakia are hereby approved for the period from 1 January 2006 to 31 December 2006. The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member Stare referred to in paragraph 1 for the implementation of those programmes and shall not exceed:
►M2 EUR 550 000 ◄ for Belgium;
EUR 155 000 for Denmark;
►M2 EUR 300 000 ◄ for Germany;
EUR 315 000 for France;
EUR 75 000 for Ireland;
EUR 675 000 for Italy;
EUR 69 000 for Cyprus;
EUR 73 000 for Latvia;
EUR 759 000 for the Netherlands;
EUR 72 000 for Austria;
►M2 EUR 38 000 ◄ for Portugal;
EUR 232 000 for Slovakia.
The financial contribution by the Community of the programmes referred to in paragraph 1 shall be for:
either the destruction of breeding poultry or the difference between the estimated value of breeding poultry and the income from the sale of the heat-treated meat obtained from such poultry;
the destruction of incubated hatching eggs;
either the destruction of non-incubated hatching eggs or the difference between the estimated value of non-incubated hatching eggs and the income from the sale of the heat-treated egg products obtained from such eggs;
the purchase of vaccines in so far as they do not interfere with the implementation of the programme;
the costs of bacteriological tests performed in the framework of official sampling as laid down in Annex III, section I to Council Directive 92/117/EEC ( 7 ), up to a maximum amount of EUR 5 per test to be reimbursed to the Member State.
CHAPTER VIII
CLASSICAL SWINE FEVER AND AFRICAN SWINE FEVER
Article 8
The programmes for the control and monitoring of:
classical swine fever presented by the Czech Republic, Germany, France, Luxembourg, Slovenia and Slovakia are hereby approved for the period from 1 January 2006 to 31 December 2006;
classical swine fever and African swine fever presented by Italy (Sardinia) are hereby approved for the period from 1 January 2006 to 31 December 2006.
The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of virological and serological tests of domestic pigs and wild boar and for the programmes of Germany, France and Slovakia also for the purchase and distribution of vaccines plus baits and shall not exceed:
EUR 35 000 for the Czech Republic;
►M2 EUR 1 200 000 ◄ for Germany;
EUR 400 000 for France;
EUR 50 000 for Italy;
EUR 15 000 for Luxembourg;
EUR 25 000 for Slovenia;
EUR 400 000 for Slovakia.
The maximum amounts of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall not exceed:
for an ELISA test |
EUR 2,5 per test; |
for the purchase of one vaccine dose |
EUR 0,5 per dose. |
CHAPTER IX
AUJESZKY’S DISEASE
Article 9
The financial contribution by the Community shall be at the rate of 50 % of the cost of laboratory tests and shall not exceed:
►M2 EUR 260 000 ◄ for Belgium;
EUR 100 000 for Spain.
CHAPTER X
HEARTWATER, BABESIOSIS, AND ANAPLASMOSIS
Article 10
CHAPTER XI
MONITORING OF TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
Article 11
The financial contribution by the Community shall be at the rate of 100 % of the eligible costs to be incurred by each Member State referred to in paragraph 1 for the implementation of those programmes and shall not exceed:
EUR 3 375 000 for Belgium;
EUR 1 640 000 for the Czech Republic;
EUR 2 380 000 for Denmark;
EUR 15 155 000 for Germany;
EUR 285 000 for Estonia;
EUR 1 625 000 for Greece;
EUR 9 945 000 for Spain;
►M2 EUR 26 065 000 ◄ for France;
EUR 6 695 000 for Ireland;
EUR 9 045 000 for Italy;
EUR 565 000 for Cyprus;
EUR 355 000 for Latvia;
EUR 770 000 for Lithuania;
EUR 140 000 for Luxembourg;
EUR 1 415 000 for Hungary;
EUR 35 000 for Malta;
►M2 EUR 5 550 000 ◄ for the Netherlands;
EUR 2 230 000 for Austria;
EUR 3 800 000 for Poland;
►M2 EUR 2 665 000 ◄ for Portugal;
EUR 410 000 for Slovenia;
EUR 845 000 for Slovakia;
EUR 1 020 000 for Finland;
EUR 1 440 000 for Sweden;
EUR 7 700 000 for the United Kingdom.
The financial contribution by the Community of the programmes referred to in paragraphs 1 and 3 shall be for the tests performed and the maximum amount shall not exceed:
EUR 7 per test, for tests carried out in bovine animals referred to in Annex III to Regulation (EC) No 999/2001;
EUR 30 per test, for tests carried out in ovine and caprine animals referred to in Annex III to Regulation (EC) No 999/2001;
EUR 145 per test, for primary molecular discriminatory tests in ovine and caprine animals carried out as referred to in Annex X, Chapter C, point 3.2(c)(i) to Regulation (EC) No 999/2001;
CHAPTER XII
ERADICATION OF BOVINE SPONGIFORM ENCEPHALOPATHY
Article 12
The financial contribution by the Community of the programmes referred to in paragraph 1 shall be at the rate of 50 % of the cost paid by the concerned Member States for compensation to owners for the value of their animals culled and destroyed in accordance with their eradication programme, up to a maximum of EUR 500 per animal and shall not exceed:
EUR 150 000 for Belgium;
EUR 750 000 for the Czech Republic;
EUR 100 000 for Denmark;
EUR 875 000 for Germany;
EUR 15 000 for Estonia;
EUR 15 000 for Greece;
EUR 1 000 000 for Spain;
►M2 EUR 100 000 ◄ for France;
EUR 2 800 000 for Ireland;
EUR 200 000 for Italy;
EUR 15 000 for Cyprus;
EUR 100 000 for Luxembourg;
EUR 60 000 for the Netherlands;
EUR 15 000 for Austria;
EUR 985 000 for Poland;
►M2 EUR 335 000 ◄ for Portugal;
EUR 25 000 for Slovenia;
EUR 65 000 for Slovakia;
EUR 25 000 for Finland;
EUR 530 000 for the United Kingdom.
CHAPTER XIII
ERADICATION OF SCRAPIE
Article 13
The financial contribution by the Community of the programmes referred to in paragraph 1 shall be at the rate of 50 % of the cost paid by the concerned Member States for compensation to owners for the value of their animals culled and destroyed in accordance with their eradication programme, up to a maximum of EUR 50 per animal and at a rate of 100 % of the cost of the analysis of samples for genotyping, up to a maximum of EUR 10 per genotyping test and shall not exceed:
EUR 100 000 for Belgium;
EUR 105 000 for the Czech Republic;
EUR 5 000 for Denmark;
EUR 1 105 000 for Germany;
EUR 6 000 for Estonia;
EUR 1 060 000 for Greece;
►M2 EUR 4 790 000 ◄ for Spain;
EUR 4 690 000 for France;
EUR 705 000 for Ireland;
EUR 530 000 for Italy;
►M2 EUR 2 815 000 ◄ for Cyprus;
EUR 10 000 for Latvia;
EUR 5 000 for Lithuania;
EUR 35 000 for Luxembourg;
EUR 50 000 for Hungary;
►M2 EUR 500 000 ◄ for the Netherlands;
EUR 15 000 for Austria;
►M2 EUR 75 000 ◄ for Portugal;
EUR 160 000 for Slovenia;
EUR 250 000 for Slovakia;
EUR 6 000 for Finland;
EUR 6 000 for Sweden;
EUR 5 740 000 for the United Kingdom.
CHAPTER XIV
GENERAL AND FINAL PROVISIONS
Article 14
The average compensation to be reimbursed to the Member States shall be calculated on the basis of the number of animals slaughtered in the Member State and:
for bovine animals, up to a maximum of EUR 300 per animal;
for sheep and goats, up to a maximum of EUR 35 per animal.
Article 15
The expenditure presented by the Member State for a financial contribution by the Community shall exclude value added tax and other taxes.
Article 16
The conversion rate for applications submitted in national currency in month ‘n’ shall be that of the tenth day of month ‘n + 1’ or for the first preceding day for which a rate is quoted.
Article 17
The financial contribution by the Community for the programmes referred to in Articles 1 to 13 shall be granted provided that the Member States implement the programmes in accordance with the relevant provisions of Community law, including rules on competition and on the award of public contracts, and subject to the conditions provided for in points (a) to (h):
bringing into force by 1 January 2006 the laws, regulations and administrative provisions by the Member State concerned for implementing the programme;
forwarding by 1 June 2006 at the latest, the preliminary technical and financial evaluation of the programme, in accordance with Article 24(7) of Decision 90/424/EEC;
for the programmes referred to in Articles 1 to 10, forwarding an intermediate report, covering the first six months of the programme, at the latest four weeks after the end of the implementation period covered by the report;
for the programmes referred to in Articles 11 to 13, forwarding a report to the Commission every month on the progress of the TSE monitoring programme and the costs paid by the Member State; that report must be forwarded within a period of four weeks following the end of the month covered by the report;
forwarding a final report by 1 June 2007 at the latest, on the technical execution of the programme accompanied by justifying evidence as to the costs paid by the Member State and the results attained during the period from 1 January 2006 to 31 December 2006;
details of the costs paid by the Member State as referred to in point (d) must be provided in computerised form in accordance with the table set out in the Annex;
implementing the programme efficiently;
no other Community contribution has been or will be asked for these measures.
Article 18
This Decision shall apply from 1 January 2006.
Article 19
This Decision is addressed to the Member States.
ANNEX
Model of computerised form giving details of costs paid by the Member States as referred to in point (f) of Article 17(1)
TSE Monitoring |
||
Member State: |
Month: |
Year: |
Tests on bovine animals |
|||
|
Number of tests |
Unit cost |
Total cost |
Tests on animals referred to in Annex III, Chapter A, Part I, points 2.1, 3 and 4.1 to Regulation (EC) No 999/2001 |
|
|
|
Tests on animals referred to in Annex III, Chapter A, Part I, points 2.2, 4.2 and 4.3 to Regulation (EC) No 999/2001 |
|
|
|
Total |
|
|
|
Tests on ovine animals |
|||
|
Number of tests |
Unit cost |
Total cost |
Tests on animals referred to in Annex III, Chapter A, Part II, point 2(a) to Regulation (EC) No 999/2001 |
|
|
|
Tests on animals referred to in Annex III, Chapter A, Part II, point 3 Regulation (EC) No 999/2001 |
|
|
|
Tests on animals referred to in Annex III, Chapter A, Part II, point 5 to Regulation (EC) No 999/2001 |
|
|
|
Total |
|
|
|
Tests on caprine animals |
|||
|
Number of tests |
Unit cost |
Total cost |
Tests on animals referred to in Annex III, Chapter A, Part II, point 2(b) to Regulation (EC) No 999/2001 |
|
|
|
Tests on animals referred to in Annex III, Chapter A, Part II, point 3 to Regulation (EC) No 999/2001 |
|
|
|
Tests on animals referred to in Annex III, Chapter A, Part II, point 5 to Regulation (EC) No 999/2001 |
|
|
|
Total |
|
|
|
Primary molecular testing with a discriminatory immuno-blotting |
|||
|
Number of tests |
Unit cost |
Total cost |
Tests on animals referred to in Annex X, Chapter C, point 3.2(c)(i) |
|
|
|
( 1 ) OJ L 224, 18.8.1990, p. 19. Decision as last amended by Regulation (EC) No 806/2003 (OJ L 122, 16.5.2003, p. 1).
( 2 ) OJ L 147, 31.5.2001, p. 1. Regulation as last amended by Commission Regulation (EC) No 1292/2005 (OJ L 205, 6.8.2005, p. 3).
( 3 ) OJ L 347, 12.12.1990, p. 27. Decision as amended by Directive 92/65/EEC (OJ L 268, 14.9.1992, p. 54).
( 4 ) OJ L 272, 18.10.2005, p. 18.
( 5 ) OJ L 160, 26.6.1999, p. 103.
( 6 ) OJ L 349, 24.12.1998, p. 1.
( 7 ) OJ L 62, 15.3.1993, p. 38.